Hattersley G, Chambers T J
Department of Histopathology, St. George's Hospital Medical School, London, United Kingdom.
Endocrinology. 1989 Apr;124(4):1689-96. doi: 10.1210/endo-124-4-1689.
The osteoclast is the cell that resorbs bone. It is known to derive from hemopoietic precursors, and a series of recent experiments has used enumeration of the tartrate-resistant acid phosphatase (TRAP)-positive multinucleate cells that develop in cultures of hemopoietic tissue as a means to analyze the regulation of osteoclast generation. These multinucleate cells have never been definitively characterized as osteoclasts, however, and we elected to assess the relationship among bone resorption (the primary function of the osteoclast), TRAP, and multinuclearity in mouse bone marrow cultures. Mouse bone marrow cells and peritoneal macrophages were incubated on plastic coverslips or bone slices for up to 14 days in the presence or absence of 1 alpha, 25-dihydroxyvitamin D3 [1 alpha,25-(OH)2D3]. Osteoclast generation, as judged by bone resorption, occurred in marrow cell cultures only in the presence of 1 alpha,25-(OH)2D3. However, TRAP-positive multinuclear cells developed both with and without the hormone. The multinuclear cells bound F4/80, a marker for macrophages that does not bind to osteoclasts. Peritoneal macrophages became multinucleate and developed TRAP positivity in culture to levels similar to those in freshly isolated osteoclasts, especially with 1 alpha,25-(OH)2D3, but remained nonresorptive. In cultures of marrow cells incubated with 1 alpha,25-(OH)2D3 bone resorption was more extensive than could readily be accounted for by the number of multinucleate cells present, and the size of excavations and extent of resorption suggested a major contribution by mononuclear cells with osteoclastic function. Thus, while TRAP and multinuclearity are reliable markers for osteoclastic phenotype in bone, they are unreliable markers in culture. Experiments designed to evaluate the regulation of osteoclast generation through enumeration of TRAP-positive multinucleate cells formed in bone marrow cultures will not only overstate, to an unknown and probably variable degree, the number of multinucleate osteoclasts that develop, but will also fail to even identify what may be a considerable and more substantial population of mononuclear cells that possess osteoclastic characteristics.
破骨细胞是负责吸收骨组织的细胞。已知其起源于造血前体细胞,最近的一系列实验通过对造血组织培养物中产生的抗酒石酸酸性磷酸酶(TRAP)阳性多核细胞进行计数,来分析破骨细胞生成的调控机制。然而,这些多核细胞从未被明确鉴定为破骨细胞,因此我们选择评估小鼠骨髓培养物中骨吸收(破骨细胞的主要功能)、TRAP和多核性之间的关系。将小鼠骨髓细胞和腹腔巨噬细胞在有无1α,25 - 二羟基维生素D3 [1α,25-(OH)2D3]的情况下,在塑料盖玻片或骨切片上孵育长达14天。仅在存在1α,25-(OH)2D3的情况下,骨髓细胞培养物中才会出现通过骨吸收判断的破骨细胞生成。然而,无论有无该激素,TRAP阳性多核细胞都会产生。这些多核细胞结合F4/80,这是巨噬细胞的标志物,而破骨细胞不与之结合。腹腔巨噬细胞在培养中会变成多核并呈现出与新鲜分离的破骨细胞相似水平的TRAP阳性,尤其是在有1α,25-(OH)2D3的情况下,但仍不具备骨吸收能力。在用1α,25-(OH)2D3孵育的骨髓细胞培养物中,骨吸收的程度比现有多核细胞数量所能轻易解释的更为广泛,并且挖掘的大小和吸收的程度表明具有破骨细胞功能的单核细胞起到了主要作用。因此,虽然TRAP和多核性在骨中是破骨细胞表型的可靠标志物,但在培养中却是不可靠的标志物。通过对骨髓培养物中形成的TRAP阳性多核细胞进行计数来评估破骨细胞生成调控的实验,不仅会在未知且可能可变的程度上高估生成的多核破骨细胞数量,还甚至无法识别可能相当数量且更具实质性的具有破骨细胞特征的单核细胞群体。